Demography of Meningioma Patients
| Patient no. | Sex | WHO grade | Age (y) | Initial location | Onset | Treatment history | PET/CT time (y) | PET/CT findings | Follow-up therapy | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 1 | 69 | Right frontal | 2005 | Craniotomy × 3, CyberKnife embolization | 12 | Positive | Bevacizumab, octreotide | Died |
| 2 | F | 2 | 82 | Right sphenoid | 2016 | Craniotomy × 2 | 1 | Positive × 2 | Proton beam therapy | Survived |
| 3 | M | 2 | 72 | Bifrontal | 2009 | Craniotomy × 3, radiation therapy | 8 | Positive | Octreotide | Died |
| 4 | M | 2 | 59 | Left skull base | 2008 | γ-knife | 10 | Positive | Octreotide | Died |
| 5 | M | 2 | 77 | Bifrontal | 2012 | Radiosurgery, craniotomy × 2 | 7 | Positive | Octreotide, bevacizumab | Died |
| 6 | M | 2 | 72 | Left frontoparietal | 2015 | Craniotomy × 1, radiation therapy | 3 | Positive | Proton beam therapy | Survived |
| 7 | F | 3 | 47 | Right frontal | 2008 | Craniotomy × 1 | 12 | Negative × 2 | Surveillance | Survived |
| 8 | F | 1 | 68 | Right skull base | 2021 | Partial resection | 1 | Positive | Radiation therapy | Survived |